Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Full details: cnb.cx/48B9gmK | CNBC
0:46
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Full details: cnb.cx/48B9gmK | CNBC
47.5K views6 months ago
FacebookCNBC
See more
Static thumbnail place holder